Pathogenesis of cutaneous lupus erythematosus

Although for decades sunlight was suspected to be involved in the development of cutaneous lupus erythematosus (CLE), only in recent years research on the effects of ultraviolet irradiation on the skin of patients with CLE has resulted in a more comprehensive model for the pathogenesis of the disease. In this model, exposure to UV light induces apoptosis of keratinocytes and the release of pro-inflammatory cytokines. In susceptible patients, the presence or even accumulation of apoptotic cells results in the induction of characteristic inflammatory skin lesions, which might be due to a delayed and pro-inflammatory clearance of these apoptotic cells. Many other factors, in part genetically determined, are involved in CLE resulting in a very heterogeneous clinical manifestation. Among these factors, presence of autoantibodies, a decreased number of regulatory T cells at the site of inflammation and increased expression of pro-inflammatory cytokines like TNFα and IFN-inducible protein myxovirus protein A have been shown to play a role in the pathogenesis of CLE.

[1]  T. Bieber,et al.  The expression pattern of interferon‐inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets , 2007, The British journal of dermatology.

[2]  H. Harris,et al.  Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus , 2007, Lupus.

[3]  A. Enk,et al.  Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. , 2007, Arthritis and rheumatism.

[4]  C. Kallenberg,et al.  Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients , 2007, Annals of the rheumatic diseases.

[5]  B. Hansen,et al.  The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. , 2007, Arthritis and rheumatism.

[6]  J. Wenzel,et al.  Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches , 2007, Experimental dermatology.

[7]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[8]  C. Kallenberg,et al.  Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? , 2006, Arthritis research & therapy.

[9]  J. Andreu,et al.  Decrease of regulatory T cells in patients with systemic lupus erythematosus , 2006, Annals of the rheumatic diseases.

[10]  A. Martin-Villalba,et al.  Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. , 2006, Arthritis and rheumatism.

[11]  Yao-Hsu Yang,et al.  Inverse correlation between CD4+ regulatory T‐cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus , 2006, Immunology.

[12]  P. Debré,et al.  Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1 , 2005, The Journal of Immunology.

[13]  L. Padyukov,et al.  Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. , 2005, Arthritis and rheumatism.

[14]  C. Kallenberg,et al.  Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy , 2005, Annals of the New York Academy of Sciences.

[15]  S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[16]  A. Rosen,et al.  Generation of novel covalent RNA-protein complexes in cells by ultraviolet B irradiation: implications for autoimmunity. , 2005, Arthritis and rheumatism.

[17]  R. Lechler,et al.  MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[18]  S. Beissert,et al.  Photosensitivity in lupus erythematosus , 2005, Autoimmunity.

[19]  J. Berlin,et al.  Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus , 2004, Lupus.

[20]  G. Plewig,et al.  Use of sunscreens to protect against ultraviolet-induced lupus erythematosus. , 2004, Arthritis and rheumatism.

[21]  K. Lauber,et al.  Clearance of apoptotic cells: getting rid of the corpses. , 2004, Molecular cell.

[22]  N. Staines,et al.  A deficiency of CD4+ CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen , 2004, Lupus.

[23]  P. Cohen,et al.  Ultraviolet B Radiation-Induced Cell Death: Critical Role of Ultraviolet Dose in Inflammation and Lupus Autoantigen Redistribution 1 , 2003, The Journal of Immunology.

[24]  J. Alcocer-Varela,et al.  Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.

[25]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[26]  T. Ruzicka,et al.  Phototesting in lupus erythematosus: a 15-year experience. , 2001, Journal of the American Academy of Dermatology.

[27]  J. McGregor,et al.  Molecular genetics of cutaneous lupus erythematosus , 2001, Clinical and experimental dermatology.

[28]  J. Davoust,et al.  Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. , 1998, Arthritis and rheumatism.

[29]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[30]  G. Plewig,et al.  Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. , 1990, Journal of the American Academy of Dermatology.

[31]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[32]  K. Hashimoto,et al.  Biological changes of human cutaneous nerves caused by ultraviolet irradiation: an ultrastructural study , 1978, The British journal of dermatology.

[33]  B. Thiers A Serology-Based Approach Combined With Clinical Examination of 125 Ro/SSA-Positive Patients to Define Incidence and Prevalence of Subacute Cutaneous Lupus Erythematosus , 2008 .

[34]  A. Torgashina,et al.  Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. , 2007, Advances in experimental medicine and biology.

[35]  C. Orfanos,et al.  Prognosis of Cutaneous Lupus Erythematosus , 2005 .

[36]  T. Ruzicka,et al.  Classification of Cutaneous Lupus Erythematosus , 2005 .

[37]  S. Grether-Beck,et al.  Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test. , 2002, European journal of dermatology : EJD.